title: Disparities of perceptions and practices related to cervical cancer prevention and the acceptability of HPV vaccination according to educational level in a French cross-sectional survey of 18-65 years old women.
abstract: BACKGROUND
  We aimed to study the relationships between educational level, women's knowledge about cervical cancer (CC), and acceptance of HPV vaccination for their daughters.
  
  
  METHODS
  We analysed data from a quantitative (self-administrated questionnaire) and qualitative (semi-structured interviews) cross-sectional study performed in 2008 among 1,229 French 18-65-year-old women recruited by general practitioners. Women were categorized into three educational level groups: low (LEL: 43.9%), medium (MEL: 33.4%) and high (HEL: 22.6%).
  
  
  RESULTS
  Knowledge about CC and its prevention was lower among LEL women. In the 180 mothers of 14-18-year-old daughters (99 LEL, 54 MEL, 45 HEL), acceptance of HPV vaccine was higher in LEL (60.4%) and MEL (68.6%) than in HEL mothers (46.8%). Among LEL mothers, those who were favourable to HPV vaccination were more likely to be young (OR = 8.44 [2.10-34.00]), to be vaccinated against hepatitis B (OR = 4.59 [1.14-18.52]), to have vaccinated their children against pneumococcus (OR = 3.52 [0.99-12.48]) and to present a history of abnormal Pap smear (OR = 6.71 [0.70-64.01]).
  
  
  CONCLUSIONS
  Although LEL women had poorer knowledge about CC and its prevention, they were more likely to accept HPV vaccination than HEL mothers.
authors.affiliation: Université Lyon 1, CNRS UMR 5558 et Centre Léon Bérard, Lyon, France.
authors.forename: Julie
authors.initials: J
authors.lastname: Haesebaert
authors.affiliation: Université Lyon 1, CNRS UMR 5558 et Centre Léon Bérard, Lyon, France.
authors.forename: Delphine
authors.initials: D
authors.lastname: Lutringer-Magnin
authors.affiliation: Institut de Cancérologie de la Loire et Université Jean Monnet de Saint-Étienne, IFR 143, Saint-Étienne, France.
authors.forename: Julie
authors.initials: J
authors.lastname: Kalecinski
authors.affiliation: Université Lyon 1, CNRS UMR 5558 et Centre Léon Bérard, Lyon, France.
authors.forename: Giovanna
authors.initials: G
authors.lastname: Barone
authors.affiliation: Sanofi-Pasteur MSD, Lyon, France.
authors.forename: Anne-Carole
authors.initials: AC
authors.lastname: Jacquard
authors.affiliation: Sanofi-Pasteur MSD, Lyon, France.
authors.forename: Yann
authors.initials: Y
authors.lastname: Leocmach
authors.affiliation: Institut de Cancérologie de la Loire et Université Jean Monnet de Saint-Étienne, IFR 143, Saint-Étienne, France.
authors.forename: Véronique
authors.initials: V
authors.lastname: Régnier
authors.affiliation: Université Lyon 1, CNRS UMR 5558 et Hospices Civils de Lyon, Lyon, France.
authors.forename: Philippe
authors.initials: P
authors.lastname: Vanhems
authors.affiliation: Institut de Cancérologie de la Loire et Université Jean Monnet de Saint-Étienne, IFR 143, Saint-Étienne, France.
authors.forename: Franck
authors.initials: F
authors.lastname: Chauvin
authors.affiliation: Université Lyon 1, CNRS UMR 5558 et Centre Léon Bérard, Lyon, France.
authors.forename: Christine
authors.initials: C
authors.lastname: Lasset
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D003430:Cross-Sectional Studies; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008875:Middle Aged; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000627:therapeutic use*; D010342:Patient Acceptance of Health Care / Q000706:statistics & numerical data; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control*; D014611:Vaccination; D055815:Young Adult
chemical_list: D053918:Papillomavirus Vaccines